MRNA

Should You Buy Moderna Before Aug. 5?

Moderna Has Some Key Approvals Ahead. Is the Stock a Buy?

MRNA Up as Influenza Vaccine Wins Unanimous FDA Advisory Panel Backing

FDA Votes in Favor of Benefit-Risk Profile for Moderna's Flu Vaccine

Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investigational Seasonal Influenza Vaccine

US FDA advisers vote in favor of Moderna's flu vaccine